Angle (AGL)

 

AGL Share PerformanceMore

52 week high82.50 21/03/16
52 week low46.55 04/01/17
52 week change -0.70 (-1.23%)
4 week volume2,117,682 02/02/17

Media for (AGL)

Presenter: Andrew Newland, Chief Executive
09/10/2014

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Selected for European Cancer ID Programme

RNS Number: 6697W Angle PLC 13 February 2017 For immediate release 13 February 2017 ANGLE plc ("the Company") PARSORTIX SELECTED FOR EUROPEAN CANCER-ID PROGRAMME ANGLE plc (AIM: AGL OTCQX: ANPCY), the specialist medtech company, is pleased to announce that it has been formally selected for CANCER-ID, the European con...

Interim Evaluation of Ovarian Cancer Study

RNS Number: 1486V Angle PLC 26 January 2017 For immediate release 26 January 2017 ANGLE plc ("the Company") POSITIVE INTERIM EVALUATION OF OVARIAN CANCER CLINICAL STUDIES Patient enrolment European study now over 90% complete and US study 70% complete Headline data from the full studies expected in Q2, 2017 ANGLE plc (A...

Interim Results

RNS Number: 1504V Angle PLC 26 January 2017 For Immediate Release 26 January 2017 ANGLE plc ("ANGLE" or "the Company") Interim Results for the six months ended 31 October 2016 OVARIAN CANCER CLINICAL STUDIES PROGRESSING WELL ANGLE plc (AIM: AGL and OTCQX: ANPCY), the specialist medtech company, today announces its unau...

ANGLE Plc to present at the Growth and Innovation Forum 2017 in London on 31 January 2017

Andrew Newland the Chief Executive of ANGLE Plc (AGL) [LSE:AGL] the specialist medtech company, is to present at th...

ANGLE schedules interims

ANGLE, the specialist medtech company, will be releasing its interim results for the six months ended 31 October on 26 Jan...

Notice of Results

RNS Number: 2482T Angle PLC 04 January 2017 For Immediate Release 04 January 2017 ANGLE plc ("ANGLE" or "the Company") Notification of Interim Results and Webcast ANGLE plc (AIM: AGL and OTCQX: ANPCY), the specialist medtech company, will be releasing its interim results for the six months ended 31 October 2016 on Thursday 26 January 2017. ...

Our AIM tip soars 60% in 2016

Matching our huge success in 2015 would always be difficult, but former AIM writer of the year Andrew Hore still mana...

ISSUE OF SHARE OPTIONS

RNS Number: 2366Q Angle PLC 28 November 2016 For immediate release 28 November 2016 ANGLE plc ("ANGLE" or the "Company") ISSUE OF SHARE OPTIONS ANGLE plc (AIM: AGL; OTCQX: ANPCY), the specialist medtech company, announces that under the shareholder approved Remuneration Policy the Remuneration Committee has approved the issu...

Fundamental DataMore

EPS-8.64
Dividend yield0 %

Equity Research (AGL)

edison investment research
ANGLE Plc
14/02/2017
Angle’s H117 business update revealed that R&D activities are progressing well, while the company booked further research use sales. The first prospective clinical studies with Angle’s liquid...
edison investment research
ANGLE Plc
14/02/2017
Angle’s H117 business update revealed that R&D activities are progressing well, while the company booked further research use sales. The first prospective clinical studies with Angle’s liquid...
ANGLE Plc
03/02/2017
Haydale Graphene (HAYD.L) 178.5p £31.15m The global nanomaterials group has announced a proposed strategic investment of £3.3m by Everpower International Holdings Co. Ltd, a New York-based investment...

Latest discussion posts More

  • Up 16% this week

    No news. Someone must be in the know ?!
    17-Feb-2017
    Good money after bad
  • Rise

    Nice rise today....hopefully someone knows something !
    15-Feb-2017
    Good money after bad
  • Re: Presentation from 31-Jan-17 Forum

    Let's hope for a much better reaction in days to come once this has been digested than we have seen today. With FDA approval likely within 12 months this surely cannot remain ...
    2-Feb-2017
    millwallfan

Users' HoldingsMore

Users who hold Angle also hold..
LLOYDS GRP.22%
TESCO22%
GLAXOSMITHKLINE15%
VODAFONE GRP.14%
RDS 'B'12%

Codes & Symbols

ISINGB0034330679
SymbolsAGL, LSE:AGL, AGL.L, AGL:LN, LON:AGL, XLON:AGL